This blog features pieces from AIM chief officers. Find summaries of recent medical literature below.
This Just In from AIM Chief Medical Officer Michelle Fiscus, MD
What’s Happening with Aluminum?
Likely you’ve heard some back-and-forth recently about the use of aluminum as an adjuvant in vaccines. Here’s what you need to know from both sides of the argument.
FDA Gives Approval to Moderna’s Spikevax COVID-19 Vaccine for Children 6 Months Through 11 years… But Only If at High Risk
On July 9, 2025, the FDA released its decision to approve the supplemental Biologics License Application (BLA) for SPIKEVAX, but only for certain ages at high risk.
What To Know About the Effectiveness of the Influenza Vaccine During the 2024-2025 Respiratory Viral Season Study
Here’s what you need to know about the study, Effectiveness of the Influenza Vaccine During the 2024-2025 Respiratory Viral Season.
Does Early MMR Vaccination Lead to Reduced Protection Against Measles?
A look at a recent study, Long-term Dynamics of Measles Virus–Specific Neutralizing Antibodies in Children Vaccinated Before 12 Months of Age.
January 2025 Study Finds Children Ages 0 to 35 month Received at Least One Invalid Vaccine Dose
A study found that 15.4% of children ages 0 to 35 months received at least one invalid vaccine dose.
New Study Finds Cost-Effective Provider Education Can Raise HPV Vaccine Initiation Rates
A study found that combining provider education with other interventions has the potential to significantly improve HPV vaccine initiation rates.